Clinical trials in hemoglobinopathies

EHA Library, Miguel R. Abboud, 219087

Epidemiology in sickle cell disease - Lessons learned from a multinational cohort in sub-Saharan Africa

EHA Library, brigitte ranque, 219086

Regulation of gene expression in hematopoiesis

EHA Library, Douglas HIGGS, 219085

The spleen in sickle cell disease

EHA Library, Valentine Brousse, 219083

The spleen in myeloproliferative neoplasms

EHA Library, Pierre Buffet, 219082

The role of the spleen in ITP

EHA Library, James Bussel, 219081

New treatment options

EHA Library, Uwe Platzbecker, 219079

Molecular genetics in clinical decision making

EHA Library, Mario Cazzola, 219078

The hematopoietic niche in MDS: from concept to therapeutic target

EHA Library, Marc Raaijmakers, 219077

Efficacy, safety and accessibility to CAR-T therapy for lymphomas

EHA Library, Peter Borchmann, 219075

ALLOGENEIC STEM CELL TRANSPLANTATION FOR PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Hanane Bouarab, 215939

CHONDROITIN SULPHATE PROTEOGLYCAN 4 POTENTIAL MARKER OF MINIMAL RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA AND BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM

EHA Library, Miloslava Hisemová, 215940

ADAM28 AGGRAVATES THE LEUKEMIA BURDEN IN A MICE MODEL AND PREDICTED A HIGH RISK OF RELAPSE IN FAVORABLE-RISK AML PATIENTS

EHA Library, Jia-Min Zhang, 215941

ANTITUMOR ACTIVITY OF BIBR1532, A SELECTIVE SMALL MOLECULE INHIBITOR OF TELOMERASE, IRRESPECTIVE OF P53 STATUS OF TUMOR CELLS

EHA Library, Atieh Pourbagheri-Sigaroodi, 215942

LOW-MYELOPEROXIDASE (MPO) MIXED-PHENOTYPE ACUTE LEUKEMIAS (MPALS) IDENTIFIED BY COMBINING CYTOCHEMISTRY AND FLOW CYTOMETRY

EHA Library, George Paterakis, 215943

SUCCESSFUL COVERAGE OF DIFFICULT TO SEQUENCE GENES (CALR, CEBPA, AND FLT3) ASSOCIATED WITH MYELOID DISORDERS USING A HYBRIDISATION-BASED ENRICHMENT APPROACH PRIOR TO NEXT-GENERATION SEQUENCING (NGS).

EHA Library, Lyudmila Georgieva, 215944

DIFFERENTIAL GENE EXPRESSION PROFILE ALTERATIONS IN CHEMORESISTANT AML CELLS FOLLOWING THEIR EXPOSURE TO IDARUBICIN AND CYTARABINE

EHA Library, Vassiliki Pappa, 215945

IMPROVING RISK STRATIFICATION IN ACUTE MYELOID LEUKEMIA WITH MRNA TECHNIQUES: BAALC AND WT1 LEVELS AFTER INDUCTION ARE BETTER THAN MORPHOLOGIC STATUS POST INDUCTION AND CYTOGENETIC AT DIAGNOSIS.

EHA Library, Carlos Rodríguez Medina, 215946

ALTERATIONS IN SERUM BILIRUBIN DURING TREATMENT WITH ENASIDENIB IN PATIENTS WITH OR WITHOUT UGT1A1 MUTATIONS

EHA Library, Amir T. Fathi, 215948

OUTCOME PREDICTION OF AML PATIENTS SUBMITTED TO ALLOGENEIC STEM CELL TRANSPLANTATION IN RECENT YEARS. A SINGLE CENTER EXPERIENCE ON 101 PATIENTS.

EHA Library, Nicola Polverelli, 215949

A DRUG-DRUG INTERACTION STUDY TO ASSESS THE EFFECT OF ACID REDUCING AGENT, LANSOPRAZOLE, ON QUIZARTINIB PHARMACOKINETICS

EHA Library, Jianke Li, 215950

EFFECT OF A HIGH-FAT AND HIGH-CALORIE MEAL ON THE PHARMACOKINETICS (PK) OF QUIZARTINIB (Q) AND ITS ACTIVE METABOLITE

EHA Library, Jianke Li, 215951

HEALTH RELATED QUALITY OF LIFE (HRQOL) IN ACUTE MYELOID LEUKEMIA (AML) PATIENTS NOT ELIGIBLE FOR INTENSIVE CHEMOTHERAPY (NIC AML): RESULTS OF A SYSTEMATIC LITERATURE REVIEW

EHA Library, Anna Forsythe, 215952

EFFICACY AND SAFETY OF C-CAG REGIMEN (CLADRIBINE,G-CSF, LOW-DOSE CYTARABINE AND ACLARUBICIN) IN PATIENTS WITH REFRACTORY/RELAPSED ACUTE MYELOID LEUKEMIA: A PHASE 2, SINGLE CENTER, SINGLE ARM STUDY.

EHA Library, yue lu, 215953

FEASIBILITY AND SAFETY OF AN EARLY INTENSIFICATION APPROACH WITH FLAG-IDA IN NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA (AML) PATIENTS WITH MORPHOLOGICAL RESIDUAL LEUKEMIA AT DAY 14 BONE MARROW AFTER 3+7.

EHA Library, Francesca Pavesi, 215954

A SUBSET OF AML PATIENTS SHOWS DIFFERENT QUIMIOSENSITIVY EX VIVO PROFILES TO ANTHRACYCLINES AND ITS COMBINATION WITH CYTARABINE; COULD PRECISION MEDICINE BE THE KEY SELECTION CRITERION?

EHA Library, Joan Ballesteros, 215957

THE ROLE OF MUTATIONS OF THE GENE FLT3 IN ACUTE MYELOID LEUKEMIA: THE EFFECT ON THE COURSE OF THE DISEASE AND THE RESULTS OF THE THERAPY

EHA Library, Asiyat Radzhabova, 215958

DO LEUKAPHERESIS IMPROVE EARLY DEATH RATES IN ACUTE MYELOID LEUKEMIA PATIENTS WITH HYPERLEUKOCYTOSIS?

EHA Library, Osman Ilhan, 215959

AGE-RELATED BACH2/PRDM1 GENE EXPRESSION ALTERATIONS IN T AND B LYMPHOCYTES FROM CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS AND AGE-MATCHED HEALTHY DONORS.

EHA Library, Pushpamali De Silva, 215960

CORRELATION BETWEEN IGHV MUTATIONAL STATUS AND AID “ON-TARGET” MOTIFS (WGCW) COUNT IN A SPANISH CLL COHORT

EHA Library, Azahara Fuentes, 215961

ANALYSIS OF THE 3′UTR REGION OF THE NOTCH1 GENE IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS

EHA Library, Nadia Bilous, 215962

EXPRESSION OF THE GENES OF THE MAIN RECEPTORS AND LIGANDS OF THE EXTERNAL PATHWAY OF APOPTOSIS IN PATIENTS WITH NEWLY DIAGNOSED CHRONIC LYMPHOCYTIC LEUKEMIA DURING RFC THERAPY

EHA Library, Sergey Zakharov, 215963

DETECTION OF MEASURABLE RESIDUAL DISEASE BY NEXT-GENERATION SEQUENCING IN PAIRED BLOOD AND BONE MARROW SAMPLES FROM PATIENTS WITH LYMPHOID MALIGNANCIES

EHA Library, Lori Muffly MD MS, 215964

MITIGATION OF TUMOR LYSIS SYNDROME (TLS) COMPLICATIONS WITH VENETOCLAX (VEN) IN CLL

EHA Library, John F. Seymour, 215965

IMMEDIATE AND LONG-TERM OUTCOMES OF SPLENECTOMY IN PATIENTS WITH NON-HODGKIN LYMPHOMA AND CHRONIC LYMPHOCYTIC LEUKEMIA COMPLICATED BY AUTOIMMUNE HEMOLYTIC ANEMIA

EHA Library, Yurij Yevstakhevych, 215966

DYNAMIC CHANGES IN HLA-DR EXPRESSION DURING SHORT-TERM AND LONG-TERM IBRUTINIB TREATMENT IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Peter Turcsayni, 215967

METHOD COMPARISON OF A NOVEL SLIDE-BASED INTEGRATED HEMATOLOGY ANALYZER AND A FLOW CYTOMETRY-BASED SYSTEM USING SAMPLES WITH TARGETED MEDICAL CONDITIONS

EHA Library, Henk Russcher, 215968

THE VALUE OF RITUXIMAB-CONTAINING CHEMOTHERAPY IN SECOND-LINE WITH OR WITHOUT PREVIOUS RITUXIMAB EXPOSURE: A POPULATION-BASED STUDY AMONG PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA IN THE NETHERLANDS

EHA Library, Lina van der Straten, 215969

PROSPECTIVE REAL WORLD DATA OF AN ONGOING POST-AUTHORIZATION SAFETY STUDY ON IDELALISIB IN PATIENTS WITH CLL AND REFRACTORY FL

EHA Library, Wolfgang Knauf, 215970

COPY NUMBER ALTERATIONS DETECTED BY A MULTIPLEX PCR GENOTYPING METHOD AND FISH IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Lei Fan, 215971

MAINTENANCE DOSING OF IBRUTINIB FOR CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL) / SMALL LYMPHOCYTIC LYMPHOMA PATIENTS

EHA Library, Raj Ramakrishna, 215972

SECOND CANCERS IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS TREATED WITH BCR INHIBITORS – RETROSPECTIVE ANALYSIS OF THE POLISH ADULT LEUKEMIA STUDY GROUP (PALG)

EHA Library, Krzysztof Jamroziak, 215973

IL-2, IL-6, IL-17 AND IL-33 IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA COMPLICATED BY AUTOIMMUNE CYTOPENIAS

EHA Library, Olha Vyhovska, 215974

PGP AND BCRP INHIBITOR AS A MODULATOR OF IMATINIB RESISTANCE

EHA Library, Ana Bela Sarmento-Ribeiro, 215975

KILLER IMMUNOGLOBULIN-LIKE RECEPTOR GENOTYPES IN TURKISH PATIENTS WITH ACUTE AND CHRONIC MYELOID LEUKEMIA

EHA Library, Emel Gürkan, 215976

HEAT SOCK PROTEIN 90 INHIBITION AS A POTENTIAL THERAPEUTIC TARGET IN CHRONIC MYELOID LEUKEMIA

EHA Library, Ana Bela Sarmento-Ribeiro, 215977

A MATHEMATICAL APPROACH TOWARDS IMMUNOLOGICAL CONTROL OF MINIMAL RESIDUAL DISEASE IN CML PATIENTS

EHA Library, Ingmar Glauche, 215978

EVOLUTION OF PLASMA LEVELS, RESPONSE AND TOLERANCE TO IMATINIB AFTER SWITCHING FROM GLIVEC® TO GENERIC IMATINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP)

EHA Library, Juan Luis Steegmann, 215979

IS THE TIME TO CYTOGENETIC RESPONSE PREDICTIVE FOR SURVIVAL IN CHRONIC MYELOID LEUKEMIA? POPULATION DATA FROM RUSSIAN CML REGISTRY AND SIMULATION MODEL.

EHA Library, Sergey Kulikov, 215980

EPIDEMIOLOGY IN CHRONIC MYELOID LEUKEMIA (CML) IN ANDALUSIA (SPAIN). RESULTS FROM THE ANDALUSIAN REGISTRY OF CML (RALMC) 2002-2016.

EHA Library, Jose Manuel Puerta-Puerta, 215981

EPIGENETIC MODULATORS SHOW IN VITRO THERAPEUTIC POTENTIAL TO TREAT B CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Ana Bela Sarmento Ribeiro, 215929

TARGET: A SURVEY OF REAL-WORLD MANAGEMENT OF CHRONIC MYELOID LEUKEMIA ACROSS 33 COUNTRIES

EHA Library, Anna turkina, 215983

SURVIVAL AFTER 1, 3 AND 5 YEARS OF TYROSINE KINASE INHIBITOR THERAPY IN SIMPLICITY, AN OBSERVATIONAL STUDY OF CHRONIC-PHASE CHRONIC MYELOID LEUKEMIA (CP-CML) PATIENTS IN ROUTINE CLINICAL PRACTICE

EHA Library, Mauricette Michallet, 215984

IMPACT OF AGE ON THE CLINICAL RESPONSE, TOXICITY AND SURVIVAL IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA TREATED WITH IMATINIB IN THE FIRST-LINE: AN ANALYSIS OF CAMELIA REGISTRY.

EHA Library, Edgar Faber, 215985

EVALUATION OF NK CELLS IN CHRONIC MYELOID LEUKEMIA PATIENTS: CORRELATION WITH RESPONSE TO TREATMENT

EHA Library, Immacolata Attolico, 215986

IMATINIB RESPONSE AND MICRORNAS PROFILE IN CML – A BIOMARKER FOR DRUG RESPONSE

EHA Library, Ana Bela Sarmento-Ribeiro, 215987

TWELVE YEARS RESULTS OF FIRST-PHASE CHRONIC MYELOID LEUKEMIA (CML) TREATMENT WITH IMATINIB 400 MG (IMATIB *) IN 222 PATIENTS.

EHA Library, Naima Abdennebi, 215988

CHRONIC MYELOID LEUKEMIA (CML) MAY CO-EXPRESS THE P210 BCR-ABL1 AND P195 BCR-ABL1

EHA Library, Susana Gonçalves Pereira, 215989

BOSUTINIB VS IMATINIB FOR NEWLY DIAGNOSED CHRONIC PHASE CHRONIC MYELOID LEUKEMIA: LEARNINGS FROM 2 PHASE 3 TRIALS (BFORE AND BELA) CONDUCTED IN DIFFERENT ERAS

EHA Library, Michael Deininger, 215990

CIRCULATING INFLAMMA-MIRNAS IN MYELODYSPLASTIC SYNDROMES

EHA Library, Antonella Poloni, 215991

HIF-1A EXPRESSION IS ASSOCIATED WITH PRIMARY RESISTANCE TO AZACITIDINE IN MDS PATIENTS – DATA FROM THE HELLENIC MDS STUDY GROUP

EHA Library, Vassiliki Pappa, 215992

HLA-G GENE AND PROTEIN EXPRESSION IN PATIENTS WITH PRIMARY MYELODYSPLASTIC SYNDROME

EHA Library, Stavroula Giannouli, 215993

DIAGNOSTIC POTENTIAL OF ALDEHYDE DEHYDROGENASES ISOENZYMES IN MDS AND AML

EHA Library, Ana Bela Sarmento Ribeiro, 215995

THE 5 - AZACITIDINE THERAPY IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOID LEUKEMIA

EHA Library, Hortensia Ionita, 215996

RISK-MITIGATION PLANS TO REDUCE INCIDENCE OF URINARY ADVERSE EVENTS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS) TREATED WITH ORAL RIGOSERTIB (RIGO) IN COMBINATION WITH AZACITIDINE (AZA).

EHA Library, Shyamala C. Navada, 215997

SOLUBLE ADHESION MOLECULE LEVELS PREDICT RESPONSE TO AZACYTIDINE IN PATIENTS WITH HIGH RISK MYELODYSPLASTIC SYNDROME – RESULTS OF A PIVOTAL TRIAL.

EHA Library, Jan M Horacek, 215998

THE ROLE OF FLT3-ITD MUTATION ON DE NOVO MDS AMONG CHINESE POPULATION

EHA Library, Shengli Xue, 215999

AZACITIDINE CAN INDUCE LIFE-THREATENING SKIN LESIONS

EHA Library, Camilla Vo, 216000

CHRONIC MYELOMONOCYTIC LEUKAEMIA A RETROSPECTIVE STUDY FROM A SINGLE CENTRE IN ROMANIA

EHA Library, Aurelia Tatic, 216001

A CASE OF SEVERE CONGENITAL NEUTROPENIA CARRYING A NOVEL HOMOZYGOUS MUTATION IN CSF3R GENE

EHA Library, Umran Caliskan, 216002

IMMUNOLOGICAL STATUS OF PATIENTS WITH DIAMOND BLACKFAN ANEMIA

EHA Library, Fatma Gumruk, 216003

CHROMOSOME FRAGILE SITE 16B AND BENIGN NEUTROPENIA: A FAMILIAR CASE STUDY

EHA Library, Nicola Stefano Fracchiolla, 216004

EPIDEMIOLOGY OF MULTIPLE MYELOMA IN A LARGE METROPOLITAN AREA OF RUSSIA (NOVOSIBIRSK)

EHA Library, Natalia Skvortsova, 216005

THE OCCURRENCE AND ECONOMIC BURDEN OF TREATMENT-INDUCED PERIPHERAL NEUROPATHY IN PATIENTS WITH MULTIPLE MYELOMA IN SWEDEN

EHA Library, Hareth Nahi, 216006

FIRST-LINE THERAPY WITH BENDAMUSTINE/PREDNISONE/BORTEZOMIB (BPV) FOR NON-TRANSPLANT ELIGIBLE SYMPTOMATIC MULTIPLE MYELOMA PATIENTS

EHA Library, Wolfgang Knauf, 216008

NON-MYELOMA KIDNEY DISEASE AND MANAGEMENT ALGORITHM IN MYELOMA PATIENTS

EHA Library, Katy Westwood, 216009

COMPARISON OF TWO MOBILIZATION REGIMENS FOR NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS.

EHA Library, Elena Mariggiò, 216010

OUTCOMES OF TREATMENT OF MULTIPLE MYELOMA IN PATIENTS REQUIRING RENAL REPLACEMENT THERAPY: “REAL WORLD” SINGLE CENTRE EXPERIENCE OVER AN 11 YEAR PERIOD

EHA Library, Aruni Ratnayake, 216011

PHASE III (IMROZ) STUDY DESIGN: ISATUXIMAB PLUS BORTEZOMIB, LENALIDOMIDE, AND DEXAMETHASONE (VRD) VERSUS VRD IN TRANSPLANT-INELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA.

EHA Library, Thierry Facon, 216012

PHASE III (IKEMA) STUDY DESIGN: ISATUXIMAB PLUS CARFILZOMIB AND DEXAMETHASONE (KD) VS KD IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM).

EHA Library, Thomas Martin, 216013

THE TREATMENT WITH PEGYLATED LIPOSOMAL DOXORUBICIN, CYCLOPHOSPHAMIDE AND DEXAMETHASINE (CED) FOR RELAPSED AND REFRACTORY MULTIPLE MYELOMA

EHA Library, Hortensia Ionita, 216014

REAL-WORLD EVIDENCE OF THE USE OF CARFILZOMIB AMONG PATIENTS WITH RELAPSED MULTIPLE MYELOMA IN EUROPE: AN INTERIM ANALYSIS FROM A PROSPECTIVE OBSERVATIONAL STUDY

EHA Library, Evangelos Terpos, 216015

LONG TERM DISEASE CONTROL WITH POMALIDOMIDE AND DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS: A REAL LIFE EXPERIENCE

EHA Library, Marina Silvia Parisi, 216016

THE CLINICAL SIGNIFICANCE OF THE IMMUNOPHENOTYPIC PROFILE OF TUMOR PLASMA CELLS IN THE BONE MARROW AND PERIPHERAL BLOOD IN MULTIPLE MYELOMA COMPLICATED BY PLASMACYTOMAS.

EHA Library, Kirill Belousov, 216017

UNINVOLVED IGA SUPPRESSION PREDICTS EVOLUTION TO SYMPTOMATIC MYELOMA IN CONTEMPORARY DIAGNOSED SMM; PRELIMINARY RESULTS

EHA Library, A. Koudouna, 216018

THE PROSPECTIVE INTERSECTORAL NATIONAL COHORT STUDY MYRIAM TO STUDY CHARACTERISTICS, TREATMENT AND OUTCOME OF PATIENTS WITH MULTIPLE MYELOMA IN GERMANY

EHA Library, Wolfgang Knauf, 216019

BORTEZOMIB INDUCTION AND MAINTENANCE THERAPY IN MULTIPLE MYELOMA PATIENTS INELIGIBLE FOR TRANSPLANTATION

EHA Library, Kameliya Milcheva, 216020

IMPACT OF NOVEL AGENTS ON AGGRESSIVE RELAPSE OF MULTIPLE MYELOMA: A SINGLE CENTER EXPERIENCE

EHA Library, Enrica Martino, 216021

A MULTI-CENTER RETROSPECTIVE STUDY OF BONE DESTRUCTION ASSOCIATED WITH 419 NEWLY DIAGNOSED MULTIPLE MYELOMA

EHA Library, Yanxia Jin, 216022

CARFILZOMIB AND DEXAMETHASONE VERSUS 8 CYCLES OF BORTEZOMIB AND DEXAMETHASONE: AN INDIRECT COMPARISON AND EXPLORATORY ANALYSIS OF THE EFFICACY AND SAFETY OF THE RANDOMIZED, PHASE 3 ENDEAVOR TRIAL

EHA Library, Katja Weisel, 216023

VENOUS THROMBOEMBOLISM IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) TREATED WITH ERYASPASE (L-ASPARAGINASE ENCAPSULATED IN RED BLOOD CELLS)

EHA Library, Yves Bertrand, 215938

EFFECTS OF IRON OVERLOAD IN CHILDREN WITH ALL

EHA Library, Katerina Bruslova, 215937

THE TREATMENT OUTCOME OF CHILDREN WİTH ACUTE LYMPHOBLASTIC LEUKEMIA:20 YEARS EXPERIENCE FROM A SINGLE CENTER IN TURKEY

EHA Library, ADALET MERAL GÜNEŞ, 215936

HEPATITIS C VIRUS INFECTION-ASSOCIATED MACROPHAGE ACTIVATION SYNDROME IN A PEDIATRIC PATIENT WHICH UNDERWENT HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Mariacristina Menconi, 215935

SEQUENTIAL USE OF IMMUNOTHERAPY IN REFRACTORY/RELAPSED B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: CLINICAL EXPERIENCE FROM A SINGLE-CENTRE

EHA Library, Nicola Stefano Fracchiolla, 215934

NOTCH PATHWAY AS A THERAPEUTIC TARGET IN ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Ana Bela Sarmento-Ribeiro, 215933

PARTHENOLIDE, AN NF-ΚB INHIBITOR, INDUCE CELL DEATH AND SUPPRESS CELL PROLIFERATION IN LYMPHOID MALIGNANCIES

EHA Library, Ana Bela Sarmento Ribeiro, 215932

INHIBITION OF DNA-PK ENHANCES CHEMOSENSITIVITY OF B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA CELLS TO DOXORUBICIN

EHA Library, Majid Safa, 215931

FOXP3 KNOCKDOWN INHIBITS THE PROLIFERATION AND REDUCES NOTCH1 EXPRESSION OF T- LYMPHOBLASTIC LEUKEMIA CELLS

EHA Library, Satoru Yonekura, 215930

EFFECTIVENESS IN REAL LIFE OF TKI TREATMENT ON CML. RESULTS FROM THE ANDALUSIAN REGISTRY OF CHRONIC MYELOID LEUKEMIA (RALMC) 2002-2016.

EHA Library, Jose Manuel Puerta-Puerta, 215982